• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.

作者信息

Diehl Anna M, Day Christopher

机构信息

From the Department of Medicine, Duke University, Durham, NC (A.M.D); and Newcastle University Medical School, Newcastle upon Tyne, United Kingdom (C.D.).

出版信息

N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.

DOI:10.1056/NEJMra1503519
PMID:29166236
Abstract
摘要

相似文献

1
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的病因、发病机制及治疗
N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.
2
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".儿童和青少年非酒精性脂肪性肝病的发病机制：从“双打击理论”到“多打击模型”。
World J Gastroenterol. 2018 Jul 21;24(27):2974-2983. doi: 10.3748/wjg.v24.i27.2974.
3
Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.非酒精性脂肪性肝炎：更广泛背景下的组织病理学基础
Surg Pathol Clin. 2018 Jun;11(2):267-285. doi: 10.1016/j.path.2018.02.013.
4
The liver's weighty problem.肝脏的重大问题。
Science. 2015 Jul 3;349(6243):18-20. doi: 10.1126/science.349.6243.18.
5
Pediatric Non-alcoholic Fatty Liver Disease.小儿非酒精性脂肪性肝病
Curr Gastroenterol Rep. 2016 May;18(5):24. doi: 10.1007/s11894-016-0498-9.
6
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.生活方式干预对非酒精性脂肪性肝病发病机制的影响。
World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633.
7
Management and diagnosis of fatty liver disease.脂肪肝疾病的管理与诊断
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):671-83. doi: 10.1586/17474124.2015.1003209. Epub 2015 Feb 26.
8
[Hyperhomocysteinemia--a predictor of inflammatory changes in the liver].[高同型半胱氨酸血症——肝脏炎症变化的一个预测指标]
Lik Sprava. 2014 Nov(11):154-5.
9
Practical approach to non-alcoholic fatty liver disease in patients with diabetes.糖尿病患者非酒精性脂肪性肝病的实用治疗方法
Diabet Med. 2015 Sep;32(9):1121-33. doi: 10.1111/dme.12725. Epub 2015 Mar 18.
10
Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.非酒精性脂肪性肝病：流行病学、发病机制及治疗意义
J Med Life. 2018 Jan-Mar;11(1):20-23.

引用本文的文献

1
Resistance Exercise in Treating Heart Failure with Preserved Ejection Fraction (HFpEF) and Obesity: Targeting Skeletal Muscle Abnormalities and Ectopic Adipose Depots.阻力运动治疗射血分数保留的心力衰竭（HFpEF）与肥胖：针对骨骼肌异常和异位脂肪堆积
Physiologia. 2025 Mar;5(1). doi: 10.3390/physiologia5010010. Epub 2025 Feb 27.
2
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状：现有证据综述
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention.
代谢功能障碍相关脂肪性肝病：心血管风险的隐匿驱动因素及新的干预靶点
Int J Mol Sci. 2025 Aug 21;26(16):8081. doi: 10.3390/ijms26168081.
4
A novel multi-parameter MRI-based model for identification of high-risk metabolic dysfunction-associated steatohepatitis.一种基于多参数磁共振成像的新型模型，用于识别高危代谢功能障碍相关脂肪性肝炎。
Eur Radiol. 2025 Aug 21. doi: 10.1007/s00330-025-11944-z.
5
Association between exposure to air pollutants and NAFLD/MAFLD: a meta-analysis.空气污染物暴露与非酒精性脂肪性肝病/代谢功能障碍相关脂肪性肝病之间的关联：一项荟萃分析。
BMC Public Health. 2025 Aug 6;25(1):2672. doi: 10.1186/s12889-025-24058-4.
6
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration.逐渐发生的DNA甲基化变化揭示了与代谢功能障碍相关的脂肪性肝病进展和表观遗传年龄加速有关的转录因子。
Clin Epigenetics. 2025 Aug 4;17(1):138. doi: 10.1186/s13148-025-01945-6.
7
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.代谢功能障碍相关脂肪性肝病患者的肝脏硬度测量：方法有效性及前景的最新进展
World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675.
8
Dissecting the Cellular Heterogeneity Underlying Liver Diseases Through the Integration of GWASs and Single-Cell RNA Sequencing.通过整合全基因组关联研究（GWAS）和单细胞RNA测序剖析肝脏疾病潜在的细胞异质性
Biology (Basel). 2025 Jun 27;14(7):777. doi: 10.3390/biology14070777.
9
Trends and demographic disparities in heart failure mortality rates in non-alcoholic fatty liver disease: a population-based retrospective study in the United States from 1999 to 2020.非酒精性脂肪性肝病中心力衰竭死亡率的趋势及人口统计学差异：一项基于美国1999年至2020年人口的回顾性研究。
Am J Cardiovasc Dis. 2025 Jun 15;15(3):166-174. doi: 10.62347/MCPC3010. eCollection 2025.
10
Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidation.CIDEB中的体细胞功能丧失突变通过增加脂肪分解和脂肪酸氧化来减轻肝脂肪变性。
J Hepatol. 2025 Jul 4. doi: 10.1016/j.jhep.2025.06.021.